Fatal	fatal	O	O	O	O
myeloencephalopathy	myeloencephalopathy	O	O	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
accidental	accidental	O	O	O	O
intrathecal	intrathecal	O	O	O	O
vincristin	vincristin	O	O	OTHERS	I
administration	administration	O	O	O	O
:	:	O	O	O	O
a	a	O	O	O	O
report	report	O	O	O	O
of	of	O	O	O	O
two	two	O	O	O	O
cases	cases	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
on	on	O	O	O	O
two	two	O	O	O	O
fatal	fatal	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
accidental	accidental	O	O	O	O
intrathecal	intrathecal	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
instillation	instillation	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
5-year	5-year	O	O	O	O
old	old	O	O	O	O
girl	girl	O	O	O	O
with	with	O	O	O	O
recurrent	recurrent	O	O	O	O
acute	acute	O	O	OTHERS	I
lymphoblastic	lymphoblastic	O	O	OTHERS	I
leucemia	leucemia	O	O	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
57-year	57-year	O	O	O	O
old	old	O	O	O	O
man	man	O	O	O	O
with	with	O	O	O	O
lymphoblastic	lymphoblastic	O	O	OTHERS	I
lymphoma	lymphoma	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
girl	girl	O	O	O	O
died	died	O	O	O	O
seven	seven	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
man	man	O	O	O	O
four	four	O	O	O	O
weeks	weeks	O	O	O	O
after	after	O	O	O	O
intrathecal	intrathecal	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Clinically	clinically	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
was	was	O	O	O	O
characterized	characterized	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
opistothonus	opistothonus	O	O	O	O
,	,	O	O	O	O
sensory	sensory	O	O	OTHERS	I
and	and	O	O	OTHERS	I
motor	motor	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
and	and	O	O	O	O
ascending	ascending	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Histological	histological	O	O	O	O
and	and	O	O	O	O
immunohistochemical	immunohistochemical	O	O	O	O
investigations	investigations	O	O	O	O
(	(	O	O	O	O
HE-LFB	he-lfb	O	O	O	O
,	,	O	O	O	O
CD-68	cd-68	O	O	O	O
,	,	O	O	O	O
Neurofilament	neurofilament	O	O	O	O
)	)	O	O	O	O
revealed	revealed	O	O	O	O
degeneration	degeneration	O	O	O	O
of	of	O	O	O	O
myelin	myelin	O	O	O	O
and	and	O	O	O	O
axons	axons	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
pseudocystic	pseudocystic	O	O	OTHERS	I
transformation	transformation	O	O	OTHERS	I
in	in	O	O	O	O
areas	areas	O	O	O	O
exposed	exposed	O	O	O	O
to	to	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
secondary	secondary	O	O	O	O
changes	changes	O	O	O	O
with	with	O	O	O	O
numerous	numerous	O	O	O	O
prominent	prominent	O	O	O	O
macrophages	macrophages	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
clinical	clinical	O	O	O	O
course	course	O	O	O	O
and	and	O	O	O	O
histopathological	histopathological	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
two	two	O	O	O	O
cases	cases	O	O	O	O
are	are	O	O	O	O
presented	presented	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
review	review	O	O	O	O
of	of	O	O	O	O
all	all	O	O	O	O
reported	reported	O	O	O	O
cases	cases	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
is	is	O	O	O	O
given	given	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
better	better	O	O	O	O
controlled	controlled	O	O	O	O
regimen	regimen	O	O	O	O
for	for	O	O	O	O
administering	administering	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
intrathecal	intrathecal	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
is	is	O	O	O	O
recommended	recommended	O	O	O	O
.	.	O	O	O	O

